ENSC

Ensysce Biosciences Inc (ENSC)

US
$ 1.8712.65%

Price Chart

Key Statistics

Market Cap
$ 2.63M
P/E Ratio
0.00
Revenue (TTM)
$ 5.21M
Volume
78.49K
52W High
$ 14.67
52W Low
$ 1.62
Dividend Yield
0.00%
Beta
1.07

Technicals

50-Day MA
3.885
200-Day MA
5.9306
52 Week High
14.67
52 Week Low
1.62

About ENSC

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States.

Employees
7
Headquarters
La Jolla, CA
CEO
Dr. D. Lynn Kirkpatrick Ph.D.

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg

Top Losers

Symbol/Name
LTP
% Chg